Obesity or Overweight
Metabolic·MeSH: Overweight
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
4 drugs in development·2 companies·6 clinical trials
Drug Pipeline by Phase
Approved(2)
Phase 3(1)
| Drug | Company |
|---|---|
| azd9550 | ASTRAZENECA PLC (AZN) |
Phase 2(1)
| Drug | Company |
|---|---|
| AZD6234 | ASTRAZENECA PLC (AZN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Obesity or Overweight?
BioSniper tracks 4 drugs in development for Obesity or Overweight across 2 companies.
How many clinical trials target Obesity or Overweight?
There are 6 clinical trials targeting Obesity or Overweight tracked by BioSniper.
What is the prevalence of Obesity or Overweight?
The estimated prevalence of Obesity or Overweight is approximately 42000.0 per 100,000 population.
Deep-dive into Obesity or Overweight
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis